Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 1;323(3):H403-H420.
doi: 10.1152/ajpheart.00204.2022. Epub 2022 Jul 1.

Mechanisms of COVID-19 pathogenesis in diabetes

Chandrakala Aluganti Narasimhulu  1 , Dinender K Singla  1
Affiliations
Review

Mechanisms of COVID-19 pathogenesis in diabetes

Chandrakala Aluganti Narasimhulu et al. Am J Physiol Heart Circ Physiol. .

Abstract

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in 190 countries. Comorbidities, particularly cardiovascular disease, diabetes, and hypertension, increase the risk of infection and poor outcomes. SARS-CoV-2 enters host cells through the angiotensin-converting enzyme-2 receptor, generating inflammation and cytokine storm, often resulting in multiorgan failure. The mechanisms and effects of COVID-19 on patients with high-risk diabetes are not yet completely understood. In this review, we discuss the variety of coronaviruses, structure of SARS-CoV-2, mutations in SARS-CoV-2 spike proteins, receptors associated with viral host entry, and disease progression. Furthermore, we focus on possible mechanisms of SARS-CoV-2 in diabetes, leading to inflammation and heart failure. Finally, we discuss existing therapeutic approaches, unanswered questions, and future directions.

Keywords: ACE2; SARS-CoV-2; cardiovascular; coronaviruses; inflammation.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
A: coronavirus disease 2019 (COVID-19) affects multiple organ systems. B: structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). E, envelope protein; M, membrane protein; N, nucleocapsid protein; PL, papain like protease; S, spike protein; 3CL, chymotrypsin-like protease; nsp, nonstructural proteins.
Figure 2.
Figure 2.
A: mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. F, phenylalanine; L, leucine; N, asparagine; P, proline; Q, glutamine; R, arginine RBD, receptor-binding domain; S, serine; T, threonine; Y, tyrosine. B: angiotensin-converting enzyme 2 (ACE2) in Ang-(1–7) formation and beneficial effects in diabetes. D, aspartic acid; F, phenylalanine; H, histidine; I, isoleucine; L, leucine; NEP, neutralendopeptidase; P, proline; PEP, prolylendopeptidase; R, arginine; ROS, reactive oxygen species; S, serine; V, valine; Y, tyrosine.
Figure 3.
Figure 3.
A: coronavirus disease 2019 (COVID-19) mechanism of action in diabetes. ACE2, angiotensin-converting enzyme 2; AGE, advanced glycation end products; ANG 2, angiotensin 2; ARDS, acute respiratory distress syndrome; ROS, reactive oxygen species. B: potential inflammatory mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in subjects with type 2 diabetes (T2D). CCL2, C-C motif chemokine ligand 2/monocyte chemotactic protein-1; CXCL-10, C-X-C motif chemokine 10; IFNγ, interferon-γ; TMPRSS2, transmembrane serine protease 2; TNF-α, tumor necrosis factor-α.
See this image and copyright information in PMC

References

    1. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 395: 470–473, 2020. [Erratum in Lancet 395: 496, 2020]. doi:10.1016/S0140-6736(20)30185-9. - DOI - PMC - PubMed
    1. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, Wölfel R, Hoelscher M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382: 970–971, 2020. doi:10.1056/NEJMc2001468. - DOI - PMC - PubMed
    1. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 104: 246–251, 2020. [Erratum in J Hosp Infect 105: 587, 2020]. doi:10.1016/j.jhin.2020.01.022. - DOI - PMC - PubMed
    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. . Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 382: 1199–1207, 2020. doi:10.1056/NEJMoa2001316. - DOI - PMC - PubMed
    1. Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 7: 11, 2020. doi:10.1186/s40779-020-00240-0. - DOI - PMC - PubMed

Publication types